HAC (Russian)
RSCI (Russian)
Ulrichsweb (Ulrich’s Periodicals Directory)
Scientific Indexing Services


DOI: https://doi.org/10.29296/25877305-2019-01-01

Professor B. Kuznik(1, 2), MD; Professor S. Davydov(1, 2), MD; Professor E. Roitman(3), Biol.D3; Yu. Smolyakov(2), Candidate of Medical Sciences; E. Guseva(2), Candidate of Medical Sciences; A. Stepanov(2), MD; Professor N. Tsybikov(1), MD; E. Fefelova(1), Candidate of Medical Sciences; N. Linkova(4, 5), Biol.D; Professor V. Khavinson(4, 6), Corresponding Member of the Russian Academy of Sciences 1-Chita State Medical Academy 2-Innovation Clinic, Academy of Health, Chita 3-N.I. Pirogov Russian National Research Medical University, Moscow 4-Saint Petersburg Institute of Bioregulation and Gerontology 5-Peter the Great Saint Petersburg Polytechnic University 6-I.P. Pavlov Institute of Physiology, Russian Academy of Sciences, Saint Petersburg

The authors investigated the relationship of cytokine GDF15 concentrations to the hemostatic system status, lipid metabolism, and cardiovascular system functions in hypertensive disease (HD) during its drug therapy alone (Group 1) and in combination with kinesitherapeutic procedures (Group 2). It was shown that GDF15 levels were 1.4 times lower in Group 1 than in Group 2 and that there were lipid metabolic changes, hypercoagulation, cardiodynamic dysfunctions, and a balance between hemodynamic and oscillatory indices, while all the studied parameters were near-normal in Group 2. It was found that kinesitherapy may be an additional effective treatment for HD.

hypertensive disease
lipid spectrum
thrombodynamic indicators
cardiodynamic and hemodynamic functions

  1. Wollert K., Kempf T. Growth differentiation factor 15 in heart failure: an update // Curr. Heart Fail Rep. – 2012; 9: 337–45. DOI: 10.1007/s11897-012-0113-9.
  2. Dominguez-Rodriguez A., Abreu-Gonzalez P., Hernandez-Baldomero I. Change in growth differentiation factor 15, but not C-reactive protein, independently predicts major cardiac events in patients with non-ST elevation acute coronary syndrome // Mediators Inflamm. – 2014; 2014: 1–5. DOI: 10.1155/2014/929536.
  3. Wiklund F., Bennet A., Magnusson P. Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality // Aging Cell. – 2010; 9: 1057–64. DOI: 10.1111/j.1474-9726. 2010.00629.
  4. Morozov K.M., Roytman E.V., Skedina M.A. i dr. Izuchenie dinamiki krovotoka v mikrocirkulyatornom rusle v usloviyah fiziologicheskoy krovopoteri // Tromboz, gemostaz i reologiya. – 2016; 67: 298–9 [Morozov K.M., Roitman E.V., Skedina M.A. et al. The study of the dynamics of blood flow in the microcirculatory bed in conditions of physiological blood loss // Thrombosis, hemostasis and rheology. – 2016; 67: 298–9 (in Russ.)].
  5. Ushakov A.V., Ivanchenko V.S., Gagarina A.A. Osobennosti profilya arterial`nogo davleniya i variabel`nosti serdechnogo ritma u bol`nyh arterial`noy gipertenziey v zavisimosti ot urovnya fizicheskoy aktivnosti i psihoe`mocional`nogo napryazheniya // Ros. kardiol. zhurn. – 2017; 4: 23–8 [Ushakov A.V., Ivanchenko V.S., Gagarina A.A. Features of the profile of blood pressure and heart rate variability in patients with arterial hypertension, depending on the level of physical activity and psychoemotional stress // Russian Cardiology Journal. – 2017; 4: 23–8 (in Russ.)]. DOI: 10.15829/1560-4071-2017-4-23-28.
  6. Davydov S.O., Kuznik B.I., Stepanov A.V. i dr. Vliyanie kineziterapii na soderzhanie «gormona molodosti» irisina u zdorovyh i bol`nyh ishemicheskoy bolezn`yu serdca // Vestnik vosstanovitel`noy mediciny. – 2015; 5: 91–8 [Davydov S.O., Kuznik B.I., Stepanov A.V. et al. The effect of kinesitherapy on the maintenance of the «hormone of youth» irisin in healthy and sick with ischemic heart disease // Bulletin of Restorative Medicine. – 2015; 5: 91–8 (in Russ.)].
  7. Davydov S.O., Stepanov A.V., Kuznik B.I. i dr. Vliyanie kineziterapii na uroven` adgezivnoy molekuly jam-a u bol`nyh gipertonicheskoy bolezn`yu // Vestnik vosstanovitel`noy mediciny. – 2017; 5: 33–7 [Davydov S.O., Stepanov A.V., Kuznik B.I. et al. Effect of kinesitherapy on the level of the adhesive molecule jam-a in patients with essential hypertension // Bulletin of Restorative Medicine. – 2017; 5: 33–7 (in Russ.)].
  8. Kuznik B.I., Davydov S.O., Stepanov O.V. i dr. «Belok molodosti» GDF11, sostoyanie sistemy gemostaza i osobennosti krovotoka u zhenshhin, stradayushhih gipertonicheskoy bolezn`yu // Tromboz, gemostaz i reologiya. – 2018; 1: 39–45 [Kuznik B.I., Davydov S.O., Stepanov O.V. et al. «Protein of Youth» GDF11, the state of the hemostasis system and blood flow peculiarities in women suffering from hypertensive disease // Thrombosis, hemostasis and rheology. – 2018; 1: 39–45 (in Russ.)]. DOI: 10.25555/THR.2018.1.0822.
  9. Panteleev M.A., Balandina A.N., Soshitova N.P. Prostranstvennaya dinamika gemostaza i tromboza: teoriya i praktika // Gemostaz, tromboz i reologiya. – 2010; 4: 48–53 [Panteleev M.A., Balandina A.N., Soshitova N.P. Spatial dynamics of hemostasis and thrombosis: theory and practice // Hemostasis, thrombosis and rheology. – 2010; 4: 48–53 (in Russ.)].
  10. Fine I., Kaminsky A., Shenkman L. A new sensor for stress measurement based on blood flow fluctuations // Dynamics and Fluctuations in Biomedical Photonics XII. SPIE Press. – 2016; 9707: 5. DOI: 10.1117/12.2212866.
  11. Corre J., Hebraud B., Bourin P. Concise review: growth differentiation factor 15 in pathology: a clinical role // Stem. Cells Transl. Med. – 2013; 12: 946–52. DOI: 10.5966/sctm.2013-0055.
  12. Johnen H., Kuffner T., Brown D. Increased expression of the TGF-b superfamily cytokine MIC-1/GDF15 protects ApoE (−/−) mice from the development of atherosclerosis // Cardiovasc. Pathol. – 2012; 21: 499–505. DOI: 10.1016/j.carpath.2012.02.003.
  13. Tsai V., Macia L., Johnen H. TGF-b Superfamily Cytokine MIC-1/GDF15 Is a Physiological Appetite and Body Weight Regulator // PLoS One. – 2013; 8: 55. DOI: 10.1371/journal.pone.0055174.
  14. Tsai V., Manandhar R., Jorgensen S. The anorectic actions of the TGFβ cytokine MIC-1/GDF15 require an intact brainstem area postrema and nucleus of the solitary tract // PLoS One. – 2014; 9: 6–37. DOI: 10.1371/journal.pone.0100370.
  15. Xanthakis V., Enserro D., Murabito J. Ideal cardiovascular health: associations with biomarkers and subclinical disease and impact on incidence of cardiovascular disease in the Framingham Offspring Study // Circulation. – 2014; 130: 1676–83. DOI: 10.1161/circulationaha.114.009273.
  16. Norozi K., Buchhorn R., Yasin A. Growth differentiation factor 15: An additional diagnostic tool for the risk stratification of developing heart failure in patients with operated congenital heart defects // Am. Heart J. – 2011; 162: 131–5. DOI: 10.1016/j.ahj.2011.03.036.
  17. Husebo G., Gronseth R., Lerner L. et al. Growth differentiation factor-15 is a predictor of important disease outcomes in patients with COPD // Eur. Respir. J. – 2017; 49 (3): 160–98. DOI: 10.1183/13993003.01298-2016.